ISRCTN83224156已完成未知
Impact of a pharmaceutical care program on liver transplant patients? compliance with immunosuppressive medication - A prospective, randomized, controlled trial using electronic monitoring
niversity Hospital Mainz, Pharmacy Department (Germany)0 个研究点目标入组 50 人开始时间: 2007年10月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
2009 results in https://pubmed.ncbi.nlm.nih.gov/19300186/ (added 10/06/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Written informed consent
- •2. Age 18 years or older
- •3. First organ transplant
- •4. Follow-up care at the University Hospital Mainz for the first year after transplantation
- •5. Administration of oral immunosuppressive therapy as capsule or tablet
- •6. Literacy (German language)
排除标准
- •Patients who are not willing to use the Medication Event Monitoring Systems® (MEMS®)
研究者
相似试验
撤回
1 期
The Effect of Hepatic Impairment on the Pharmacokinetics of BalovaptanAutism Spectrum DisorderNCT03912350Hoffmann-La Roche
已完成
1 期
A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver DysfunctionHepatic ImpairmentHealthy VolunteersNCT05478603Pfizer24
已完成
1 期
Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic FunctionHealthyNCT00418626Novartis Pharmaceuticals27
已完成
1 期
A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.Small Cell Lung CarcinomaNCT05329623Novartis Pharmaceuticals33
已完成
1 期
A Study of Danoprevir in Healthy Volunteers And Patients With Hepatic ImpairmentHealthy VolunteerNCT01185873Hoffmann-La Roche81